Loading resource…

KDIGO
The KDIGO 2025 Clinical Practice Guideline addresses the evaluation and treatment of anemia in patients with chronic kidney disease. It covers various aspects including the use of iron therapy, erythropoiesis-stimulating agents (ESAs), and red blood cell transfusions. The guideline emphasizes the importance of balancing risks and benefits when initiating treatment, particularly in relation to hemoglobin thresholds. It also includes algorithms for managing anemia in different patient populations.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

Integrated CKD Management Guidelines for Uganda
Same clinical topic · Nephrology

KDIGO 2026 CLINICAL PRACTICE GUIDELINE FOR DIABETES AND CHAPTER 1, CHAPTER 2, & CHAPTER 4 UPDATE DRAFT
Same clinical topic · Nephrology

KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology

KDIGO-2024-CKD-Guideline
Same clinical topic · Nephrology

DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE: SYNOPSIS OF THE KDIGO 2022 CLINICAL PRACTICE GUIDELINE UPDATE
Same clinical topic · Nephrology

KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS
Same clinical topic · Nephrology

KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
Same clinical topic · Nephrology

TREATMENT OF HYPERKALEMIA IN ADULTS
Same clinical topic · Nephrology